Results of blood and cerebrospinal fluid (CSF) analysis of the patient
| Date | Oligoclonal bands | Serum anti-GAD (units/ml)(normal range <1) | CSF anti-GAD (units/ml) |
|---|---|---|---|
| anti-GAD, antiglutamic acid decarboxylase. | |||
| 30 Jul 2001 | – | Negative | |
| 07 Aug 2001 | Negative | – | – |
| 16 May 2002 | – | 1.1 | – |
| 10 Dec 2002 | – | 0.5 | – |
| 31 Oct 2003 | – | 0.2 | – |
| 19 Nov 2003 | Negative | 0.1 | 3.2 |
| 09 Jan 2004 | Intravenous rituximab (375 mg/m2) administered | ||
| 26 Jan 2004 | – | 0.2 | 0 |
| 02 Apr 2004 | Negative | 0.3 | 0 |
| Intravenous rituximab (375 mg/m2) per week×4 | |||
| 30 Apr 2004 | Negative | 0.3 | 0 |